leisure time -WSS

leisure time

author：knowledge 2025-09-30 15:23:10 - browse：11

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

explore

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Readout Newsletter: CAR

Male and female sex labels in research insufficient, scientists say

Steward Health Care Massachusetts hospitals face fiscal disaster

WuXi out of biotech trade group, U.S. and China relations to blame

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

People can get long Covid without testing positive for virus: Study

Novavax promises a turnaround & Lilly roils the obesity market

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Jerome Adams on the need for new antivirals for Covid

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Novavax promises a turnaround & Lilly roils the obesity market

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

BioMarin wins approval for gene therapy to treat hemophilia A

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

explore

How to save health care price transparency rules

President Biden's budget: Here's what you might have missed

National associations that represent hospice owe an apology

FDA advisory panel to debate high blood pressure devices

Ebola: Gilead Sciences antiviral shows promise as new treatment

Health officials lay out plans to cope with respiratory virus season

explore

focus

explore

hotspot